The Captial Market (CapitalMarket.com) rating for Thyrocare Technologies IPO is 44. Their analysis recommends Avoid, However active risk seekers can try for the IPO.

Reviewer	Rating Score	Rating
Capital Market	44	Avoid, However active risk seekers can try

Thyrocare Technologies IPO Review by Dilip Davda (Apply)

[Dilip Davda] Considering the brand image and the operational methods, the company is poised for bright prospects ahead. Investment in this IPO will bring reasonable rewards in coming years. Investment may be considered for short to long term. Read detail review...

Thyrocare Technologies IPO Review by Members

Thyrocare Technologies IPO Reviews, analysis and views by popular members. Read Thyrocare Technologies Ltd. IPO reviews by retail investors to find recommended ipo to buy.

Thyrocare Technologies IPO Review Summary by Members

Review By	Apply	May Apply	Neutral	Avoid
Count	0	0	0	0
%	0.00	0.00	0.00	0.00

Member	Review
No recommendation found. Be the first to post the recommendation.

Manage Recommendations

Note:

The recommendations or analysis of public issues posted above expresses the views of its author and does not represent the views of Chittorgarh.com or its staff.
We reserve the right to remove any objectionable post without providing a reason.

Thyrocare Technologies IPO Review & Recommendations

Thyrocare Technologies IPO Review Summary from brokers and analysts

Thyrocare Technologies IPO Capital Market Rating

Thyrocare Technologies IPO Review by Dilip Davda (Apply)

Thyrocare Technologies IPO Review by Members

Thyrocare Technologies IPO Review Summary by Members

Read more about Thyrocare Technologies IPO